MindBio Therapeutics Statistics
Total Valuation
CSE:MBIO has a market cap or net worth of CAD 5.46 million. The enterprise value is 9.86 million.
Market Cap | 5.46M |
Enterprise Value | 9.86M |
Important Dates
The last earnings date was Tuesday, May 13, 2025.
Earnings Date | May 13, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
CSE:MBIO has 546.20 million shares outstanding. The number of shares has decreased by -40.06% in one year.
Current Share Class | 546.20M |
Shares Outstanding | 546.20M |
Shares Change (YoY) | -40.06% |
Shares Change (QoQ) | -0.46% |
Owned by Insiders (%) | 8.34% |
Owned by Institutions (%) | n/a |
Float | 500.66M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | -9.66 |
PB Ratio | -1.00 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -6.74 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.01
Current Ratio | 0.01 |
Quick Ratio | 0.01 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -2.05 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -364.90% |
Return on Invested Capital (ROIC) | n/a |
Return on Capital Employed (ROCE) | 18.50% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -90.00% in the last 52 weeks. The beta is 0.13, so CSE:MBIO's price volatility has been lower than the market average.
Beta (5Y) | 0.13 |
52-Week Price Change | -90.00% |
50-Day Moving Average | 0.01 |
200-Day Moving Average | 0.02 |
Relative Strength Index (RSI) | 53.04 |
Average Volume (20 Days) | 455,562 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CSE:MBIO had revenue of CAD -565,340 and -1.46 million in losses. Loss per share was -0.01.
Revenue | -565,340 |
Gross Profit | -565,340 |
Operating Income | -954,812 |
Pretax Income | -1.47M |
Net Income | -1.46M |
EBITDA | n/a |
EBIT | -954,812 |
Loss Per Share | -0.01 |
Balance Sheet
The company has 12,777 in cash and 4.46 million in debt, giving a net cash position of -4.45 million or -0.01 per share.
Cash & Cash Equivalents | 12,777 |
Total Debt | 4.46M |
Net Cash | -4.45M |
Net Cash Per Share | -0.01 |
Equity (Book Value) | -5.44M |
Book Value Per Share | -0.03 |
Working Capital | -5.16M |
Cash Flow
Operating Cash Flow | -274,518 |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | 168.89% |
Pretax Margin | 259.52% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
CSE:MBIO does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 40.06% |
Shareholder Yield | n/a |
Earnings Yield | -26.78% |
FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
CSE:MBIO has an Altman Z-Score of -583.88. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -583.88 |
Piotroski F-Score | n/a |